Joao Xavier

Full Member

Memorial Sloan Kettering Cancer Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (18)

Different forms of epithelial-to-mesenchymal transition (EMT) manifest during tumor progression. Little is known about the mechanistic basis and functional role of these distinct EMTs. We explored this question in lung adenocarcinoma (LUAD) primitive progenitors, which are competent to enter dormancy in response to transforming growth factor-β (TGFβ) upon metastatic dissemination. The TGFβ response in these cells includes growth arrest and a full EMT that subsequently transitions into an atypical mesenchymal state of round morphology and lacking actin stress fibers. TGFβ drives this transition by inducing expression of the actin depolymerizing protein gelsolin, which converts a migratory, stress-fiber-rich phenotype into a cortical actin-rich, spheroidal state. This transition lowers the biomechanical stiffness of metastatic progenitors and protects them from killing by cytotoxic lymphocytes. Gelsolin-deficient LUAD progenitors can enter dormancy but succumb to immune surveillance. Thus, quiescent LUAD metastatic progenitors undergo an atypical EMT to avert immune surveillance during TGFβ-driven metastatic dormancy.

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Disruption of the gut microbiota during cancer treatment, particularly in allogeneic hematopoietic cell transplantation (allo-HCT), is a major contributor to adverse clinical outcomes, including gut-borne bloodstream infections. Accurately forecasting microbial population dynamics under clinical perturbations, such as antibiotic administration, could inform treatment strategies that reduce the risk of infection. However, traditional models like the Generalized Lotka-Volterra (gLV), which consider only pairwise interactions of constant sign and magnitude, are limited in their ability to capture the real-world nonlinear dynamics of multispecies microbiomes following ecosystem disturbances. Here, we introduce a perturbation-augmented Neural Ordinary Differential Equation (pNODE) framework that flexibly models microbial population dynamics in continuous time, integrating both microbial abundances and time-resolved antibiotic perturbations. Using both synthetic and real clinical data from over 1,000 allo-HCT patients, we demonstrate that pNODEs outperform gLV in predictive accuracy, robustness to noise, and the ability to forecast critical events, such as the intestinal expansion of an opportunistic pathogen. Notably, we demonstrate that running a pre-trained pNODE in generative mode to simulate prospective Bacilli abundance trajectories from an initial sample and antibiotic timeline yields scores that accurately predict subsequent Enterococcus infections in held-out cohorts, outperforming baseline and ground-truth-based predictors. Because pNODEs are purely data-driven dynamical systems, they can generate artifacts, such as small negative abundance values, when run in generative mode; nevertheless, our results show that these artifacts do not impair the model’s ability to encode clinically relevant ecological structure and may even enhance it. Our findings demonstrate the potential of pNODEs as a next-generation tool for modeling clinical microbiome dynamics, with applications for predicting infections in immunocompromised patients hospitalized for cancer treatment.

Year:

2025

In hematopoietic cell transplant patients, intestinal Candida parapsilosis expansion and translocation cause life-threatening candidemia, yet how commensal intestinal bacteria prevent Candida expansion remains incompletely defined. Here, we trained a machine learning model on supernatant metabolomic profiles of commensal bacteria to identify bacteria-derived inhibitors of fungal growth, with valeric and butyric acid as top hits. Experimental validation confirmed in silico predictions in three systems. First, in patient fecal samples, valeric and butyric acid levels inversely correlated with C. parapsilosis growth. Second, in vitro, valeric acid potently inhibited C. parapsilosis growth by causing intracellular acidification. Third, administration of glycerol valerate, and free or microencapsulated valeric acid blunted C. parapsilosis growth at murine intestinal sites where valeric acid could be detected. Thus, machine learning could identify a mechanistic driver of trans-kingdom ecology limiting C. parapsilosis intestinal expansion and may inform strategies to reduce patient risk of developing candidiasis during high-risk periods.

Year:

2025

Understanding the rewired metabolism underlying organ-specific metastasis in breast cancer could help identify strategies to improve the treatment and prevention of metastatic disease. Here, we used a systems biology approach to compare metabolic fluxes used by parental breast cancer cells and their brain- and lung-homing derivatives. Divergent lineages had distinct, heritable metabolic fluxes. Lung-homing cells maintained high glycolytic flux despite low levels of glycolytic intermediates, constitutively activating a pathway sink into lactate. This strong Warburg effect was associated with a high ratio of lactate dehydrogenase (LDH) to pyruvate dehydrogenase (PDH) expression, which correlated with lung metastasis in patients with breast cancer. Although feature classification models trained on clinical characteristics alone were unable to predict tropism, the LDH/PDH ratio was a significant predictor of metastasis to the lung but not to other organs, independent of other transcriptomic signatures. High lactate efflux was also a trait in lung-homing metastatic pancreatic cancer cells, suggesting that lactate production may be a convergent phenotype in lung metastasis. Together, these analyses highlight the essential role that metabolism plays in organ-specific cancer metastasis and identify a putative biomarker for predicting lung metastasis in patients with breast cancer. Significance: Lung-homing metastatic breast cancer cells express an elevated ratio of lactate dehydrogenase to pyruvate dehydrogenase, indicating that ratios of specific metabolic gene transcripts have potential as metabolic biomarkers for predicting organ-specific metastasis.

Year:

2025

Year:

2024

Natural killer (NK) cells are a vital part of the innate immune system capable of rapidly clearing mutated or infected cells from the body and promoting an immune response. Here, we find that NK cells activated by viral infection or tumor challenge increase uptake of fatty acids and their expression of carnitine palmitoyltransferase I (CPT1A), a critical enzyme for long-chain fatty acid oxidation. Using a mouse model with an NK cell–specific deletion of CPT1A, combined with stable 13 C isotope tracing, we observe reduced mitochondrial function and fatty acid–derived aspartate production in CPT1A-deficient NK cells. Furthermore, CPT1A-deficient NK cells show reduced proliferation after viral infection and diminished protection against cancer due to impaired actin cytoskeleton rearrangement. Together, our findings highlight that fatty acid oxidation promotes NK cell metabolic resilience, processes that can be optimized in NK cell–based immunotherapies.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (18)

Kevin Byrne

Dublin City University

IRELAND
View details

Daniel Davis

The University of Manchester

UNITED KINGDOM
View details

Rebecca Delconte

Group Leader

Peter MacCallum Cancer Institute

AUSTRALIA
View details

Khemlal Nirmalkar

Research Scientist

Arizona State University

UNITED STATES
View details

Deepti Mathur

Assistant Professor

Ohio State University

UNITED STATES
View details

Chen Liao

Assistant Professor

Dartmouth College

UNITED STATES
View details

David Weiss

Professor

Emory University School of Medicine

UNITED STATES
View details

Jonathan Peled

Director

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

Joan Massague

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

Christine Iacobuzio-Donahue

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

Gacser Attila

Director

University of Szeged

HUNGARY
View details

Min-Sik Lee

Assistant Professor

Pohang University of Science and Technology

SOUTH KOREA
View details

Jonas Schluter

Assistant Professor

NYU School of Medicine

UNITED STATES
View details

Salvatore ALAIMO

Associate Professor

University of Catania

ITALY
View details

Rosa Krajmalnik-Brown

Arizona State University

UNITED STATES
View details

Tobias M Hohl

Member

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

Ana Djukovic

Group Leader

Centro de Investigacion Principe Felipe

SPAIN
View details

Alfredo Ferro

Full Professor

Università degli Studi di Napoli Federico II

ITALY
View details